Table 6

- Multivariate logistic regression analysis of risk factor of multiple drug resistance in urinary tract infection patients.

Variables	B	S.E.	Wald	P-value	Odd ratio	95% CI
						Lower	Upper
Age	0.01	0.009	3	0.083	0.98	0.98	1
Gender	0.57	0.35	2.65	0.1	0.58	0.28	1.12
UTI in ≤1 year	3.4	0.77	19.25	<0.001^*	0.03	0.007	0.15
Urologic diseases	0.51	0.4	1.58	0.209	0.59	0.26	1.33
Escherichia coli	0.001	0.41	0.001	0.999	0.99	0.44	2.24
Klebsiella pneumoniae	0.46	0.44	1.1	0.292	0.62	0.26	1.49
Proteus mirabilis	1.5	0.54	7.67	0.006^*	0.22	0.07	0.64
Enterococcus faecium	1.08	0.72	2.22	0.136	0.33	0.08	1.4
Cipro	0.25	0.43	0.34	0.556	1.29	0.54	3.05
Ceftrixone	1.83	0.69	3.94	0.047^*	0.25	0.06	0.98
Meropinum or meropenem	0.45	0.63	0.5	0.477	0.63	0.18	2.21
levofloxacin	0.02	0.89	0.001	0.978	0.97	0.17	5.58
Tazocine	0.56	0.47	1.4	0.236	0.56	0.22	1.44
Augmentin	1.02	0.74	1.19	0.166	0.35	0.08	1.53
Linezolid	0.55	1.6	0.11	0.731	0.57	0.02	13.26
Constant	3.09	0.8	14.94	<0.001	22.15

↵^* Significant relationship.UTI: urinary tract infection, CI: confidence interval, Exp (B): expected beta, S.E: standard error